Investigation of the Role of Serum Matrix Gla-Protein as a Biomarker of Calcific Aortic Valve Disease
DOI:
https://doi.org/10.29169/1927-5951.2019.09.03.3Keywords:
Calcific aortic valve disease (CAVD), serum biomarker, screening, ELISA, uncarboxylated matrix Gla-protein (ucMGP).Abstract
Background: Calcific aortic valve disease (CAVD) is a major contributor to cardiovascular morbidity and mortality. Circulating total uncarboxylated Matrix ?-carboxyglutamate (Gla) protein (t-ucMGP) is a promising biomarker for rapid screening of subjects prone to cardiovascular calcification who may need more invasive vascular diagnostics. Preliminary data show that low t-ucMGP levels are indicative for prevalent vascular calcification. Hence, the aim of our study was to investigate the possible role of circulating t-ucMGP as a biomarker may help in identification patients with CAVD, taking into consideration that CAVD is a form of vascular calcification.
Methods & Materials: We analyzed serum t-ucMGP levels by enzyme-linked immunosorbent assay (ELISA) in 50 patients with echocardiographically proven CAVD and 21 control subjects.
Results: Serum t-ucMGP levels were significantly lower in patients with CAVD (29.29±12.18 nmol/l) compared to the control group (36.84±21.79 nmol/l, p = 0.003).
Conclusion: Serum t-ucMGP may help as a noninvasive biomarker for identification of these patients.
References
Mathieu P, Boulanger M-C, Bouchareb R. Molecular biology of calcific aortic valve disease: Towards new pharmacological therapies. Expert Rev Cardiovasc Ther 2014; 12(7): 851-62.
https://doi.org/10.1586/14779072.2014.923756
O'Brien KD. Pathogenesis of calcific aortic valve disease: A disease process comes of age (and a good deal more). Arterioscler Thromb Vasc Biol 2006; 26(8): 1721-8.
https://doi.org/10.1161/01.ATV.0000227513.13697.ac
Sainger R, Grau JB, Branchetti E, Poggio P, Lai E, Koka E, et al. Comparison of transesophageal echocardiographic analysis and circulating biomarker expression profile in calcific aortic valve disease. J Heart Valve Dis 2013; 22(2): 156-65.
Beckmann E, Grau JB, Sainger R, Poggio P, Ferrari G. Insights into the use of biomarkers in calcific aortic valve disease. J Heart Valve Dis 2010; 19(4): 441-52.
Mathieu P, Boulanger M-C. Basic mechanisms of calcific aortic valve disease. Can J Cardiol 2014; 30(9): 982-93.
https://doi.org/10.1016/j.cjca.2014.03.029
Towler DA. Molecular and cellular aspects of calcific aortic valve disease. Circ Res 2013; 113(2): 198-208.
https://doi.org/10.1161/CIRCRESAHA.113.300155
Freeman RV, Otto CM. Spectrum of calcific aortic valve disease: Pathogenesis, disease progression, and treatment Strategies. Circulation. 2005; 111(24): 3316-26.
https://doi.org/10.1161/CIRCULATIONAHA.104.486738
Zeng Y, Sun R, Li X, Liu M, Chen S, Zhang P. Pathophysiology of valvular heart disease (Review). Exp Ther Med 2016; 11(4): 1184-8.
https://doi.org/10.3892/etm.2016.3048
Dweck MR, Boon NA, Newby DE. Calcific aortic stenosis: A disease of the valve and the myocardium. J Am Coll Cardiol 2012; 60(19): 1854-63.
https://doi.org/10.1016/j.jacc.2012.02.093
Leopold JA. Cellular mechanisms of aortic valve calcification. Circ Cardiovasc Interv 2012; 5(4): 605-14.
https://doi.org/10.1161/CIRCINTERVENTIONS.112.971028
Bostrom KI, Rajamannan NM, Towler DA. The regulation of valvular and vascular sclerosis by osteogenic morphogens. Circ Res 2011; 109(5): 564-77.
https://doi.org/10.1161/CIRCRESAHA.110.234278
Bossé Y, Mathieu P, Pibarot P. Genomics: The next step to elucidate the etiology of calcific aortic valve stenosis. J Am Coll Cardiol 2008; 51(14): 1327-36.
https://doi.org/10.1016/j.jacc.2007.12.031
Fusaro M, Crepaldi G, Maggi S, Galli F, D'Angelo A, Calò L, et al. Vitamin K, bone fractures, and vascular calcifications in chronic kidney disease: An important but poorly studied relationship. J Endocrinol Invest 2011; 34(4): 317-23.
https://doi.org/10.1007/BF03347093
Schurgers LJ, Uitto J, Reutelingsperger CP. Vitamin K-dependent carboxylation of matrix Gla-protein: A crucial switch to control ectopic mineralization. Trends Mol Med 2013; 19(4): 217-26.
https://doi.org/10.1016/j.molmed.2012.12.008
Schurgers LJ, Spronk HM, Soute BA, Schiffers PM, DeMey JG, Vermeer C. Regression of warfarin-induced medial elastocalcinosis by high intake of vitamin K in rats. Blood. 2007; 109(7): 2823-31.
Hackeng TM, Rosing J, Spronk HMH, Vermeer C. Total chemical synthesis of human matrix Gla protein. Protein Sci 2001; 10(4): 864-70.
https://doi.org/10.1110/ps.44701
Schurgers LJ, Barreto DV, Barreto FC, Liabeuf S, Renard C, Magdeleyns EJ, et al. The circulating inactive form of matrix gla protein is a surrogate marker for vascular calcification in chronic kidney disease: A preliminary report. Clin J Am Soc Nephrol 2010; 5(4): 568-75.
https://doi.org/10.2215/CJN.07081009
Epstein M. Matrix Gla-protein (MGP) not only inhibits calcification in large arteries but also may be renoprotective: Connecting the dots. EBioMedicine 2016; 4: 16-7.
https://doi.org/10.1016/j.ebiom.2016.01.026
Schurgers LJ, Cranenburg ECM, Vermeer C. Matrix Gla-protein: The calcification inhibitor in need of vitamin K. Thromb Haemost 2008; 100(4): 593-603.
Proudfoot D, Shanahan CM. Molecular mechanisms mediating vascular calcification: Role of matrix Gla protein. Nephrology. 2006; 11(5): 455-61.
https://doi.org/10.1111/j.1440-1797.2006.00660.x
Mayer O, Seidlerová J, Bruthans J, Filipovský J, Timoracká K, Vanek J, et al. Desphospho-uncarboxylated matrix Gla-protein is associated with mortality risk in patients with chronic stable vascular disease. Atherosclerosis 2014; 235(1): 162-8.
https://doi.org/10.1016/j.atherosclerosis.2014.04.027
Cranenburg EC, Vermeer C, Koos R, Boumans ML, Hackeng TM, Bouwman FG, et al. The circulating inactive form of matrix Gla Protein (ucMGP) as a biomarker for cardiovascular calcification. J Vasc Res 2008; 45(5): 427-36.
https://doi.org/10.1159/000124863
Schurgers LJ, Teunissen KJ, Knapen M, Kwaijtaal M, van Diest R, Appels A, et al. Novel conformation-specific antibodies against matrix{gamma}-carboxyglutamic acid (Gla) protein: Undercarboxylated matrix Gla protein as marker for vascular calcification. Arterioscler Thromb Vasc Biol 2005; 25: 1629-33.
https://doi.org/10.1161/01.ATV.0000173313.46222.43
Theuwissen E, Smit E, Vermeer C. The role of vitamin K in soft-tissue calcification. Adv Nutr 2012; 3(2): 166-73.
https://doi.org/10.3945/an.111.001628
Price PA, Faus SA, Williamson MK. Warfarin causes rapid calcification of the elastic lamellae in rat arteries and heart valves. Arterioscler Thromb Vasc Biol 1998; 18(9): 1400-7.
https://doi.org/10.1161/01.ATV.18.9.1400
Venardos N, Bennett D, Weyant MJ, Reece TB, Meng X, Fullerton DA. Matrix Gla protein regulates calcification of the aortic valve. J Surg Res 2015; 199(1): 1-6.
https://doi.org/10.1016/j.jss.2015.04.076
Koos R, Krueger T, Westenfeld R, Kühl HP, Brandenburg V, Mahnken AH, et al. Relation of circulating matrix Gla-protein and anticoagulation status in patients with aortic valve calcification. Thromb Haemost 2009; 101(04): 706-13.
https://doi.org/10.1160/TH08-09-0611
Cranenburg ECM, Schurgers LJ, Magdeleyns EJ, Vermeer C, Koos R, Brandenburg VM, et al. Characterisation and potential diagnostic value of circulating matrix Gla protein (MGP) species. Thromb Haemost 2010; 104(4): 811-22.
Downloads
Published
Issue
Section
License
Copyright (c) 2019 Amal Al Nawasreh , Hussam Shebli , Sahar Fahoum
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
Similar Articles
- Sovan Pattanaik, Sudam Chandra Si, Sudhanshu Sekhar Rout, Anindya Bose , Siva Shankar Nayak, In Silico Design & Development of Some Selected Flavonols Against Beta–Glucuronidase Inhibitory Activity , Journal of Pharmacy and Nutrition Sciences : Vol. 5 No. 1 (2015)
- Sifan Chen, Qing Wei, Yanshuang Sun, Xincai Xiao, Zili Zhang, Liangru Ke, Niman Zhou, Zhiming Shan, Xiang Feng, Wei Zhu, Pioglitazone Ameliorates Lipid Metabolic Disorder in KKAy Mice , Journal of Pharmacy and Nutrition Sciences : Vol. 1 No. 2 (2011)
- Md. Saddam Hussain, Mohammad Salim Hossain , Md. Mamun Or Rashid, Antiobesity and Lipid Lowering Activitiy of Vigna unguiculata (L) Walp. Seed in High Fat Diet Induced Obese Mice , Journal of Pharmacy and Nutrition Sciences : Vol. 9 No. 4 (2019)
- Abderrezak Khelfia, Mohammed Azzouz, Rania Abtroun, Mohammed Reggabi, Berkahoum Alamira, Direct Determination of Selenium in Serum Matrix by Electrothermal Atomic Absorption Spectrometry: Application on Healthy Individuals from Algeria , Journal of Pharmacy and Nutrition Sciences : Vol. 8 No. 1 (2018)
- Sousan Kolahi, Amir Ghorbanihaghjo, Ali-Reza Khabbazi, Mehrzad Hajialilo , Hale Farzin, The Effect of Fish Oil Supplement on Serum Antioxidant Level in Patient with Rheumatoid Arthritis , Journal of Pharmacy and Nutrition Sciences : Vol. 3 No. 4 (2013)
- Isabel Veloso Alves Pereira, Claudia Pinto Marques Souza de Oliveira, José Tadeu Stefano, Nathalia Cavalheiro Halla, João Avancini Ferreira Alves, Francisco Rafael Martins Laurindo, Flair José Carrilho, Yo Jyo Hen Shi Ko (YHK) Modulates the Expression of Proteins Involved in de novo Lipogenesis and Lipid Exportation in Experimental Nonalcoholic Steatohepatitis (NASH) , Journal of Pharmacy and Nutrition Sciences : Vol. 3 No. 1 (2013)
- N.V. Zaitseva, M.A. Zemlyanova, V.N. Zvezdin , T.I. Akafieva, Biological Effects of Manganese Oxide Nanoparticles after Peroral Intake , Journal of Pharmacy and Nutrition Sciences : Vol. 3 No. 4 (2013)
- Eman Aly Sadeek Fadlalla, Cardio-Nephroprotective Effects of Guava and Olive Leaves Extracts on Doxorubicin-Induced Toxicity in Rats , Journal of Pharmacy and Nutrition Sciences : Vol. 8 No. 3 (2018)
- Robinson, B. Lu, I. Edirisinghe , C.T. Kappagoda, Effect of Grape Seed Extract on Blood Pressure in Subjects with Pre-Hypertension , Journal of Pharmacy and Nutrition Sciences : Vol. 2 No. 2 (2012)
- C.D. Volko , U.D. Rohr, Can Plants’ Ability for DNA Repair and Stress Defense be Used against Patients’ Circulating Tumor Cells? , Journal of Pharmacy and Nutrition Sciences : Vol. 5 No. 3 (2015)
You may also start an advanced similarity search for this article.